DK1370529T3 - Substituerede dimethyl-[-1(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-aminer og anvendelse som analgetika - Google Patents

Substituerede dimethyl-[-1(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-aminer og anvendelse som analgetika

Info

Publication number
DK1370529T3
DK1370529T3 DK02750542T DK02750542T DK1370529T3 DK 1370529 T3 DK1370529 T3 DK 1370529T3 DK 02750542 T DK02750542 T DK 02750542T DK 02750542 T DK02750542 T DK 02750542T DK 1370529 T3 DK1370529 T3 DK 1370529T3
Authority
DK
Denmark
Prior art keywords
piperidin
ylmethyl
cyclohexyl
amines
phenyl
Prior art date
Application number
DK02750542T
Other languages
Danish (da)
English (en)
Inventor
Michael Sattlegger
Elke Reissmueller
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK1370529T3 publication Critical patent/DK1370529T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK02750542T 2001-03-14 2002-03-13 Substituerede dimethyl-[-1(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-aminer og anvendelse som analgetika DK1370529T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10112198A DE10112198A1 (de) 2001-03-14 2001-03-14 Substituierte Dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amine

Publications (1)

Publication Number Publication Date
DK1370529T3 true DK1370529T3 (da) 2006-05-22

Family

ID=7677392

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02750542T DK1370529T3 (da) 2001-03-14 2002-03-13 Substituerede dimethyl-[-1(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-aminer og anvendelse som analgetika

Country Status (23)

Country Link
US (1) US7049327B2 (cs)
EP (1) EP1370529B1 (cs)
JP (1) JP2004526726A (cs)
KR (1) KR20040012733A (cs)
CN (1) CN1496352A (cs)
AT (1) ATE315551T1 (cs)
BR (1) BR0208243A (cs)
CA (1) CA2440758A1 (cs)
CZ (1) CZ20032455A3 (cs)
DE (2) DE10112198A1 (cs)
DK (1) DK1370529T3 (cs)
EC (1) ECSP034768A (cs)
ES (1) ES2256499T3 (cs)
HU (1) HUP0302800A2 (cs)
IL (1) IL157893A0 (cs)
MX (1) MXPA03007967A (cs)
NO (1) NO20034029L (cs)
PE (1) PE20020926A1 (cs)
PL (1) PL364415A1 (cs)
RU (1) RU2003129061A (cs)
SK (1) SK11122003A3 (cs)
WO (1) WO2002072550A1 (cs)
ZA (1) ZA200307964B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646332B (zh) * 2014-11-09 2018-05-25 复旦大学 氨基甲基哌啶类衍生物及其制备方法和药物用途
KR102603671B1 (ko) * 2017-01-17 2023-11-17 메비아스 디스커버리 인코포레이티드 치환된 3-디알킬아미노메틸-피페리딘-4-일-벤즈아미드 및 이를 제조 및 사용하는 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL40064A0 (en) * 1972-08-07 1972-10-29 Univ Tel Aviv Phencyclidine and its derivatives as short-time acting midriatics
WO1998055478A1 (fr) * 1997-06-03 1998-12-10 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Nouveaux derives de phencyclidines, des procedes pour leur preparation et des compositions pharmaceutiques les contenant
US4598153A (en) * 1984-12-19 1986-07-01 The United States Of America As Represented By The Department Of Health And Human Services Metaphit, a specific acylating agent for the [3 H] phencyclidine
US5155212A (en) * 1986-05-21 1992-10-13 Abbott Laboratories Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit
HUT77318A (hu) * 1994-09-30 1998-03-30 Novartis Ag. 1-Acil-4-/(alifás amino)-piperidin/-származékok, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
DE10000312A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate

Also Published As

Publication number Publication date
SK11122003A3 (sk) 2004-01-08
ATE315551T1 (de) 2006-02-15
NO20034029D0 (no) 2003-09-11
CZ20032455A3 (cs) 2003-12-17
KR20040012733A (ko) 2004-02-11
PE20020926A1 (es) 2002-10-26
ES2256499T3 (es) 2006-07-16
MXPA03007967A (es) 2004-10-15
RU2003129061A (ru) 2005-04-10
JP2004526726A (ja) 2004-09-02
PL364415A1 (en) 2004-12-13
US20040127516A1 (en) 2004-07-01
DE50205593D1 (de) 2006-04-06
DE10112198A1 (de) 2002-09-19
CN1496352A (zh) 2004-05-12
NO20034029L (no) 2003-11-13
HUP0302800A2 (hu) 2003-11-28
EP1370529B1 (de) 2006-01-11
IL157893A0 (en) 2004-03-28
ZA200307964B (en) 2004-09-14
EP1370529A1 (de) 2003-12-17
US7049327B2 (en) 2006-05-23
CA2440758A1 (en) 2002-09-19
ECSP034768A (es) 2003-10-28
BR0208243A (pt) 2004-03-09
WO2002072550A1 (de) 2002-09-19

Similar Documents

Publication Publication Date Title
MXPA03005018A (es) Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos, y su uso.
MXPA03005019A (es) Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos y su uso.
AU2002219173A1 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
NO20002787L (no) Nye forbindelser
AU2003257465A1 (en) Substituted diaryl heterocycles, method for the production and use thereof as medicaments
DK1427415T3 (da) Forbindelser indeholdende lactam og derivater heraf som faktor Xa-hæmmere
NO20042906L (no) Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
AU2003239302A1 (en) Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
UY28348A1 (es) Compuestos novedosos
NO20006138L (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
TR200100054T2 (tr) Paroksetin metansülfonat
HRP20041203A2 (en) Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
HUP0300002A3 (en) Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
DK1453810T3 (da) Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament indeholdende samme
HUP0500137A2 (en) Pyrrolidine-2-ones as factor xa inhibitors, process for producing them and pharmaceutical compositions containing the same
NO20054787L (no) Indenderivater som farmasotiske midler
EP1566446A4 (en) BETA-1,4-MANNOBIOSE-CONTAINING COMPOSITION
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
NO20004904D0 (no) C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som medikamenter
DK1370529T3 (da) Substituerede dimethyl-[-1(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-aminer og anvendelse som analgetika
DK1411057T3 (da) [3,,4.a:3,4-c]carbazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DE50107490D1 (de) Stoffgemisch enthaltend bisphenol a